SRR antibody
Ref. 3D-10R-5926
| 100µl | Arrêté |
Informations sur le produit
The SRR antibody is a monoclonal antibody that has shown promising results in the field of life sciences. It is specifically designed to target and inhibit the activity of SRR, a phosphatase enzyme involved in various cellular processes. This antibody has been shown to have cytotoxic effects on cancer cells by activating TNF-related apoptosis-inducing ligand (TRAIL), a protein that induces programmed cell death. Additionally, the SRR antibody has been found to reduce microvessel density and fibrinogen levels, indicating its potential as a therapeutic agent for angiogenesis-related disorders. This medicament holds great promise for researchers and medical professionals seeking innovative solutions in the field of growth factor inhibitors and targeted therapies.
